Triple
T4492426
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Alnylam Pharmaceuticals |
E100609
|
entity |
| Predicate | collaboratesWith |
P37
|
FINISHED |
| Object |
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
|
E446849
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Vir Biotechnology | Statement: [Alnylam Pharmaceuticals, collaboratesWith, Vir Biotechnology]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Vir Biotechnology Context triple: [Alnylam Pharmaceuticals, collaboratesWith, Vir Biotechnology]
-
A.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
B.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
C.
Verily Life Sciences LLC
Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
-
D.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
E.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Vir Biotechnology Triple: [Alnylam Pharmaceuticals, collaboratesWith, Vir Biotechnology]
Generated description
Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Vir Biotechnology Target entity description: Vir Biotechnology is a clinical-stage immunology company focused on developing treatments and prophylactics for serious infectious diseases using antibody, T cell, and other immune-based technologies.
-
A.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
B.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
C.
Verily Life Sciences LLC
Verily Life Sciences LLC is a health-focused research and technology company that develops tools and platforms to collect, organize, and analyze health data, particularly in areas like clinical research, precision health, and disease management.
-
D.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company known for developing innovative antibody-based therapies for serious diseases, including eye disorders, cancer, and inflammatory conditions.
-
E.
Janssen Biotech
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd43cdf15081909a4fa2585ff63b3e |
completed | March 20, 2026, 12:55 p.m. |
| NER | Named-entity recognition | batch_69bd556f99b48190ae60506a35b43c29 |
completed | March 20, 2026, 2:10 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69bd67b40fd4819098636b6f29304312 |
completed | March 20, 2026, 3:28 p.m. |
| NEDg | Description generation | batch_69bd688e84fc8190a8900be40e3cf694 |
completed | March 20, 2026, 3:32 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69bd69bcf10c8190bd6ceb6bc604b3f5 |
completed | March 20, 2026, 3:37 p.m. |
Created at: March 20, 2026, 12:59 p.m.